Dr. Brindusa Taranu
Head of Global Product Safety Surveillance
Philip Morris International

Brindusa Taranu is a dedicated physician and accomplished leader in safety surveillance, with over 20 years of experience. She currently heads the Global Product Safety Surveillance Team at Philip Morris International. Her extensive background includes roles in patient safety, clinical trials, medical affairs, and drug development within the pharmaceutical industry. She is committed to raising awareness about the safety profiles of smoke-free products, establishing post-market safety surveillance standards across the tobacco industry, and contributing to tobacco harm reduction.

Sessions with Dr. Brindusa Taranu

11:30 - 12:30
This panel would discuss the role PMTA post-market authorization surveillance could play in helping get more FDA authorized smoke-free products to market while protecting against concerns about youth and non-users. Panelists could provide their perspectives on the best approach to improve public health, including the pros and cons of FDA implementing the precautionary principle vs. relying on post-market surveillance in making PMTA decisions.

Moderators

  • Dr. Jessica Zdinak

    Founder and Chief Research Officer, Applied Research and Analysis Company

Speakers